Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.
Insights
/
News

Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.

Date September 22, 2021
Category News
Flare Capital Partners

We invest in exceptional founders transforming healthcare.

Our entrepreneurs are addressing important issues across the entire healthcare technology industry.

our approach
Share insight